Nec-1s

Alternative name

5 – ((7-Cl-1H-indol-3-yl) methyl) -3-methylimidazolidine-2,4-dione); 7-Cl-O-Nec-1

Peptide sequence: No

Appearance: Solid yellow

CAS #: 852391-15-2

Molecular formula: C₁₃H₁₂ClN₃O₂

Molecular weight: 277.71

Purity: ≥96% by TLC and LC-MS

Solubility: DMSO

SMILES

CN1C (= O) C (NC1 = O) CC2 = CNC3 = C2C = CC = C3Cl

InChi

InChI = 1S / C13H12ClN3O2 / c1-17-12 (18) 10 (16-13 (17) 19) 5-7-6-15-11-8 (7) 3-2-4-9 (11) 14 / h2-4,6,10,15H, 5H2,1H3, (H, 16,19)

InChi key

WIKGAEMMNQTUGL-UHFFFAOYSA-N

PubChem CID: 643953

Handling: Protect from light and moisture.

Storage conditions: -20 ° C

Shipping conditions: Gel Pack

USE: For research use only! It is not for use in humans.

Abstract

Necrostatin-1 (NEC-1) is widely used in disease models to examine the contribution of receptor-interacting protein kinase (RIPK) 1 in cell death and inflammation. We studied three Nec-1 analogues: Nec-1, the active inhibitor of RIPK1, inactive Nec-1 (Nec-1i), its inactive variant, and stable Nec-1 (Nec-1s), its most stable variant. We report that Nec-1 is identical to methyl-thiohydantoin-tryptophan, an inhibitor of the potent immunomodulatory enzyme indolamine 2,3-dioxygenase (IDO).

Both Nec-1 and Nec-1i inhibited human IDO, but Nec-1 did not, as predicted by molecular modelling. Therefore, Nec-1s is a more specific RIPK1 inhibitor that lacks the targeting effect of IDO. Next, although Nec-1i was approximately 100 times less effective than Nec-1 in inhibiting human RIPK1 kinase activity in vitro, it was only 10 times less potent than Nec-1 and Nec-1s in a necroptosis assay. in mice and became even equipotent at high concentrations.

Along the same lines, in vivo, high doses of Nec-1, Nec-1i and Nec-1s equally well-prevented tumour necrosis factor (TNF) -induced mortality, excluding the use of NEC-1i as an inactive control. Paradoxically, low doses of Nec-1 or Nec-1i, but not Nec-1s, even sensitized mice to TNF-induced mortality. Importantly, Nec-1s did not show this low dose toxicity, again emphasizing the preferred use of Nec-1 in vivo. Our findings have important implications for the interpretation of Nec-1-based data in experimental disease models.

Leave a Reply

Je e-mailadres zal niet getoond worden. Vereiste velden zijn gemarkeerd met *

Related Post

Centromere Protein I (CENP-I) Is Upregulated in Gastric Cancer, Predicts Poor Prognosis, and Promotes Tumor Cell Proliferation and Migration

Centromere Protein I (CENP-I) wordt opgereguleerd bij maagkanker, voorspelt een slechte prognose en bevordert de proliferatie en migratie van tumorcellenCentromere Protein I (CENP-I) wordt opgereguleerd bij maagkanker, voorspelt een slechte prognose en bevordert de proliferatie en migratie van tumorcellen

Dit onderzoek was gericht op het onderzoeken van de expressie en mobiele werking van het centromeer huishouden van eiwitten (CENP’s), met name centromeer eiwit I (CENP-I), bij de meeste maagkankers   (GC) en erkende de

The inhibitory effect and mechanism of quetiapine on tumor progression in hepatocellular carcinoma in vivo

Het remmende effect en mechanisme van quetiapine op tumorprogressie bij hepatocellulair carcinoom in vivoHet remmende effect en mechanisme van quetiapine op tumorprogressie bij hepatocellulair carcinoom in vivo

Hepatocellulair carcinoom (HCC) is de eerste  tumor  van de lever en de vierde belangrijkste reden achter de  meeste aan kanker gerelateerde overlijdens. Nog niet zo lang geleden wees een aantal onderzoeken op het antitumorpotentieel  van antipsychotica. Quetiapine, een